v.salgado

TL2 Moderator · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 8 September 2025 · last posted 4d

83Posts here

2Topics

1Solutions

1.6kLikes received

1.1kLikes given

22Badges

190Days visited

3.8kPosts read

Recent activity

Full stream

What is genuinely unknown about long-term amylin agonism Replied, post #81 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 2 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
Does a peptide degrade silently, with no visual change? Replied, post #76 · Practice › Storage & stability · 22 Jul 2026 · 21 likes I read post #74 twice before replying, because I had assumed the opposite. Container choice matters: the material of the vial, the rubber closure, the fill volume all…
I joined for one answer and stayed for a year — what changed my mind Replied, post #98 · Start Here › Welcome · 21 Jul 2026 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Seven-day rolling means and why weekly readings mislead Replied, post #28 · Outcomes › Progress reports · 14 Jul 2026 · 16 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
Revisiting: Protein density versus volume when you cannot eat much Replied, post #56 · Nutrition & Training › Protein & intake · 12 Jul 2026 · 1 like On post #52 — agreed on the reasoning, with one qualification. Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients…
CJC-1295 with and without DAC: what the modification does Replied, post #109 · Compounds › Secretagogues & GH axis · 11 Jul 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
I joined for one answer and stayed for a year — what changed my mind Replied, post #73 · Start Here › Welcome · 10 Jul 2026 · 8 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
What to include when your question involves a chromatogram — one year on Replied, post #60 · Start Here › How to Ask · 2 Jul 2026 · 29 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
Aggregate verification data across the directory, with caveats Replied, post #6 · Sourcing › Independent verification · 20 Jun 2026 · 0 likes I read post #4 twice before replying, because I had assumed the opposite. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #45 · Evidence › Journal club · 19 Jun 2026 · 5 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
How shortages have affected compounding permissions — does this still hold? Replied, post #9 · marked as the solution · Access › Shortages · 4 Jun 2026 · 7 likes post #8 is right about the mechanism and I think understates the practical bit. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #29 · Practice › Dosing & titration · 18 May 2026 · 7 likes On post #25 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…